Stress hyperglycaemia as a result of a catecholamine producing tumour in an infant

Anne Mariëtte de Grauw1, Dick Mul2, Max M van Noesel3

  • 1Department of Pediatrics, HAGAziekenhuis/Juliana Children's Hospital, The Hague, The Netherlands.

BMJ Case Reports
|September 6, 2015
PubMed

Insights

Stress-induced hyperglycemia in children is usually benign. However, this case highlights a rare neuroblastoma in an infant, where hyperglycemia was the initial symptom, indicating a serious underlying condition.

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Oncology
  • Neuroendocrine Tumors

Background:

  • Hyperglycemia in children presenting to the emergency department is often stress-related and considered benign.
  • This case examines a rare instance where hyperglycemia was the first sign of a malignant neuroendocrine tumor.

Observation:

  • An 11-month-old girl presented with hyperglycemia (234 mg/dL), elevated glycosylated hemoglobin (44 mmol/mol), sweating, flushing, hypertension, and tachypnea.
  • Urinalysis revealed high levels of catecholamine intermediates, and an abdominal ultrasound identified a right adrenal gland mass.

Findings:

  • Histological examination confirmed the diagnosis of neuroblastoma, a metabolically active neuroendocrine malignancy.
  • The patient experienced periods of hyperglycemia, sweating, flushing, hypertension, and tachypnea, consistent with catecholamine excess.

Implications:

  • This case underscores the importance of investigating persistent or unusual hyperglycemia in children, even in the absence of typical diabetic symptoms.
  • It highlights neuroblastoma as a potential, albeit rare, cause of significant hyperglycemia in pediatric patients.
  • Early recognition of hyperglycemia as a presenting symptom can lead to timely diagnosis and treatment of pediatric neuroendocrine malignancies.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.1K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337